Quick Answer
Altamira Therapeutics Ltd. reported Total Assets of $8.65 million for the year ending 2024.
- Altamira Therapeutics Ltd. showed a decrease of -5.4% in Total Assets from 2023 to 2024.
- This data is from Altamira Therapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on April 30, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2016 to 2024), Altamira Therapeutics Ltd.'s Total Assets has declined by 75.7%.
- Historical annual values: Fiscal year 2024: $8.65 million | Fiscal year 2023: $9.14 million | Fiscal year 2022: $6.81 million | Fiscal year 2021: $19.17 million | Fiscal year 2020: $20.80 million | Fiscal year 2019: $9.23 million | Fiscal year 2018: $9.88 million | Fiscal year 2017: $17.83 million | Fiscal year 2016: $35.66 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: